Lanzkron SM - Search Results

1

Cytokine induction of platelet activation.

Lumadue JA, Lanzkron SM, Kennedy SD, Kuhl DT, Kickler TS. Lumadue JA, et al. Among authors: lanzkron sm. Am J Clin Pathol. 1996 Dec;106(6):795-8. doi: 10.1093/ajcp/106.6.795. Am J Clin Pathol. 1996. PMID: 8980357

2

Idiopathic Acquired Hemophilia A with Undetectable Factor VIII Inhibitor.

Abt NB, Streiff MB, Gocke CB, Kickler TS, Lanzkron SM. Abt NB, et al. Among authors: lanzkron sm. Case Rep Hematol. 2014;2014:484563. doi: 10.1155/2014/484563. Epub 2014 May 14. Case Rep Hematol. 2014. PMID: 24955264 Free PMC article.

3

Quantitative sensory testing and pain-evoked cytokine reactivity: comparison of patients with sickle cell disease to healthy matched controls.

Campbell CM, Carroll CP, Kiley K, Han D, Haywood C Jr, Lanzkron S, Swedberg L, Edwards RR, Page GG, Haythornthwaite JA. Campbell CM, et al. Pain. 2016 Apr;157(4):949-956. doi: 10.1097/j.pain.0000000000000473. Pain. 2016. PMID: 26713424 Free PMC article.

4

A case-control analysis of hyperhemolysis syndrome in adults and laboratory correlates of complement involvement.

Merrill SA, Brodsky RA, Lanzkron SM, Naik R. Merrill SA, et al. Among authors: lanzkron sm. Transfusion. 2019 Oct;59(10):3129-3139. doi: 10.1111/trf.15445. Epub 2019 Jul 11. Transfusion. 2019. PMID: 31292968 Clinical Trial.

5

Venous thromboembolism in adults with sickle cell disease: a serious and under-recognized complication.

Naik RP, Streiff MB, Haywood C Jr, Nelson JA, Lanzkron S. Naik RP, et al. Am J Med. 2013 May;126(5):443-9. doi: 10.1016/j.amjmed.2012.12.016. Am J Med. 2013. PMID: 23582935 Free PMC article.

6

Quality improvement process in a sickle cell infusion center.

Whiteman LN, Lanzkron S, Stewart RW, Haywood C Jr, Strouse JJ, Feldman L. Whiteman LN, et al. Am J Med. 2015 May;128(5):541-4. doi: 10.1016/j.amjmed.2014.11.020. Epub 2014 Dec 9. Am J Med. 2015. PMID: 25498167

7

Mortality and Access to Kidney Transplantation in Patients with Sickle Cell Disease-Associated Kidney Failure.

Bae S, Johnson M, Massie AB, Luo X, Haywood C Jr, Lanzkron SM, Grams ME, Segev DL, Purnell TS. Bae S, et al. Among authors: lanzkron sm. Clin J Am Soc Nephrol. 2021 Mar 8;16(3):407-414. doi: 10.2215/CJN.02720320. Epub 2021 Feb 25. Clin J Am Soc Nephrol. 2021. PMID: 33632759 Free PMC article.

8

Look into my eyes: An unusual first presentation of sickle cell disease.

Sood R, Jiramongkolchai K, Streiff M, Gonzalez C, Shanbhag S, Lanzkron S, Arevalo JF, Naik R. Sood R, et al. Am J Hematol. 2017 Sep;92(9):968-971. doi: 10.1002/ajh.24787. Epub 2017 Jun 9. Am J Hematol. 2017. PMID: 28494508 Free PMC article. No abstract available.

9

Hospitalization rates and costs of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea.

Lanzkron S, Haywood C Jr, Segal JB, Dover GJ. Lanzkron S, et al. Am J Hematol. 2006 Dec;81(12):927-32. doi: 10.1002/ajh.20703. Am J Hematol. 2006. PMID: 16924648 Free article.

10

Examining the characteristics and beliefs of hydroxyurea users and nonusers among adults with sickle cell disease.

Haywood C Jr, Beach MC, Bediako S, Carroll CP, Lattimer L, Jarrett D, Lanzkron S. Haywood C Jr, et al. Am J Hematol. 2011 Jan;86(1):85-7. doi: 10.1002/ajh.21883. Am J Hematol. 2011. PMID: 21117058 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

176 results

Search Page

Filters